Contemporary management of atherosclerotic renovascular disease: Before and after ASTRAL

Nephrology

Volumn 16, Issue 5, 2011, Pages 457-467

  Ritchie, James ^a   Chrysochou, Constantina ^a   Kalra, Philip A ^a  

^a HOPE HOSPITAL   (United Kingdom)

Author keywords

angioplasty; ASTRAL; atherosclerotic renovascular disease (ARVD); biomarkers; hypertension

Indexed keywords

ACETYLSALICYLIC ACID; BRAIN NATRIURETIC PEPTIDE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; RAPAMYCIN; VASCULOTROPIN;

ACUTE KIDNEY FAILURE; ADJUVANT THERAPY; ANGIOCARDIOGRAPHY; ANGIOPLASTY; BARE METAL STENT; BRACHYTHERAPY; CARDIOVASCULAR DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; DOPPLER FLOWMETRY; DRUG ELUTING STENT; ECHOGRAPHY; EMBOLIC PROTECTION DEVICE; HUMAN; HYPERTENSION; LUNG EDEMA; MAGNETIC RESONANCE ANGIOGRAPHY; MORTALITY; NEPHROSCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROTEINURIA; REVASCULARIZATION; REVIEW; STENOSIS; STENT; TREATMENT OUTCOME; UNITED STATES;

ANGIOPLASTY; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BRACHYTHERAPY; EMBOLISM; HUMANS; KIDNEY DISEASES; PREVALENCE; PROGNOSIS; STENTS;

EID: 79959864136     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2011.01474.x     Document Type: Review

References (94)

1. Choudhri AH, Cleland JG, Rowlands PC, Tran TL, McCarty M, al-Kutoubi MA,. Unsuspected renal artery stenosis in peripheral vascular disease. BMJ 1990; 301 (6762): 1197-8.
2. Farrington K, Udayaraj U, Gilg J, Feehally J,. UK Renal Registry 11th Annual Report (December 2008): Chapter 3 ESRD incident rates in 2007 in the UK: National and centre-specific analyses. Nephron. Clin. Pract. 2009; 111 (Suppl 1): c13-41.
3. Wheatley K, Ives N, Gray R, et al,. Revascularization versus medical therapy for renal-artery stenosis. N. Engl. J. Med. 2009; 361 (20): 1953-62.
4. Plouin PF, Chatellier G, Darne B, Raynaud A,. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis: A randomized trial. Essai Multicentrique Medicaments vs Angioplastie (EMMA) Study Group. Hypertension 1998; 31: 823-9. (Pubitemid 28108582)
5. van de Ven PJ, Kaatee R, Beutler JJ, et al,. Arterial stenting and balloon angioplasty in ostial atherosclerotic renovascular disease: A randomised trial. Lancet 1999; 353 (9149): 282-6. (Pubitemid 29088121)
6. van Jaarsveld BC, Krijnen P, Pieterman H, et al,. The effect of balloon angioplasty on hypertension in atherosclerotic renal-artery stenosis. Dutch Renal Artery Stenosis Intervention Cooperative Study Group. N. Engl. J. Med. 2000; 342 (14): 1007-14. (Pubitemid 30180647)
7. Webster J, Marshall F, Abdalla M, et al,. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J. Hum. Hypertens. 1998; 12: 329-35. (Pubitemid 28274364)
8. Bax L, Woittiez AJ, Kouwenberg HJ, et al,. Stent placement in patients with atherosclerotic renal artery stenosis and impaired renal function: A randomized trial. Ann. Intern. Med. 2009; 150 (12): 840-8, W150-1.
9. Hansen KJ, Edwards MS, Craven TE, et al,. Prevalence of renovascular disease in the elderly: A population-based study. J. Vasc. Surg. 2002; 36: 443-51.
10. Borgel J, Springer S, Ghafoor J, et al,. Unrecognized secondary causes of hypertension in patients with hypertensive urgency/emergency: Prevalence and co-prevalence. Clin. Res. Cardiol. 2010; 99: 499-506.
11. Kalra PA, Guo H, Kausz AT, et al,. Atherosclerotic renovascular disease in United States patients aged 67 years or older: Risk factors, revascularization, and prognosis. Kidney Int. 2005; 68: 293-301. (Pubitemid 43181388)
12. Olin JW, Melia M, Young JR, Graor RA, Risius B,. Prevalence of atherosclerotic renal artery stenosis in patients with atherosclerosis elsewhere. Am. J. Med. 1990; 88 (1N): 46N-51N. (Pubitemid 20055403)
13. Harding MB, Smith LR, Himmelstein SI,. Renal artery stenosis: Prevalence and associated risk factors in patients undergoing routine cardiac catheterization. J. Am. Soc. Nephrol. 1992; 2 (11): 1608-16.
14. Khosla S, Kunjummen B, Manda R, et al,. Prevalence of renal artery stenosis requiring revascularization in patients initially referred for coronary angiography. Catheter Cardiovasc. Interv. 2003; 58: 400-3. (Pubitemid 36259235)
15. Hansen KJ, Tribble RW, Reavis SW, et al,. Renal duplex sonography: Evaluation of clinical utility. J. Vasc. Surg. 1990; 12: 227-36. (Pubitemid 20279898)
16. Kohler TR, Zierler RE, Martin RL, et al,. Noninvasive diagnosis of renal artery stenosis by ultrasonic duplex scanning. J. Vasc. Surg. 1986; 4: 450-6. (Pubitemid 17183320)
17. Motew SJ, Cherr GS, Craven TE, et al,. Renal duplex sonography: Main renal artery versus hilar analysis. J. Vasc. Surg. 2000; 32: 462-9, 469-71.
18. Rountas C, Vlychou M, Vassiou K, et al,. Imaging modalities for renal artery stenosis in suspected renovascular hypertension: Prospective intraindividual comparison of color Doppler US, CT angiography, GD-enhanced MR angiography, and digital substraction angiography. Ren. Fail. 2007; 29: 295-302. (Pubitemid 46752349)
19. Eriksson P, Mohammed AA, De Geer J, et al,. Non-invasive investigations of potential renal artery stenosis in renal insufficiency. Nephrol. Dial. Transplant. 2010; 25: 3607-14.
20. Kay J, Bazari H, Avery LL, Koreishi AF,. Case records of the Massachusetts General Hospital. Case 6-2008. A 46-year-old woman with renal failure and stiffness of the joints and skin. N. Engl. J. Med. 2008; 358: 827-38.
21. Aime S, Caravan P,. Biodistribution of gadolinium-based contrast agents, including gadolinium deposition. J. Magn. Reson. Imaging 2009; 30: 1259-67.
22. Bahrami S, Raman SS, Sauk S, et al,. Ten-year experience with nephrogenic systemic fibrosis: Case-control analysis of risk factors. J. Comput. Assist. Tomogr. 2009; 33: 819-23.
23. Tsushima Y, Kanal E, Thomsen HS,. Nephrogenic systemic fibrosis: Risk factors suggested from Japanese published cases. Br. J. Radiol. 2010; 83: 590-5.
24. George SJ, Webb SM, Abraham JL, Cramer SP,. Synchrotron X-ray analyses demonstrate phosphate-bound gadolinium in skin in nephrogenic systemic fibrosis. Br. J. Dermatol. 2010; 163: 1077-81.
25. Perazella MA,. Tissue deposition of gadolinium and development of NSF: A convergence of factors. Semin. Dial. 2008; 21: 150-4.
26. Frenzel T, Lengsfeld P, Schirmer H, Hutter J, Weinmann HJ,. Stability of gadolinium-based magnetic resonance imaging contrast agents in human serum at 37 degrees C. Invest. Radiol. 2008; 43 (12): 817-28.
27. Chrysochou C, Power A, Shurrab AE, et al,. Low risk for nephrogenic systemic fibrosis in nondialysis patients who have chronic kidney disease and are investigated with gadolinium-enhanced magnetic resonance imaging. Clin. J. Am. Soc. Nephrol. 2010; 5: 484-9.
28. Martin DR, Krishnamoorthy SK, Kalb B, et al,. Decreased incidence of NSF in patients on dialysis after changing gadolinium contrast-enhanced MRI protocols. J. Magn. Reson. Imaging 2010; 31: 440-6.
29. Conlon PJ, Athirakul K, Kovalik E, et al,. Survival in renal vascular disease. J. Am. Soc. Nephrol. 1998; 9: 252-6. (Pubitemid 28092073)
30. Conlon PJ, Little MA, Pieper K, Mark DB,. Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int. 2001; 60: 1490-7. (Pubitemid 32960044)
31. Kalra PA, Guo H, Gilbertson DT, et al,. Atherosclerotic renovascular disease in the United States. Kidney Int. 2010; 77: 37-43.
32. Wright JR, Shurrab AE, Cooper A, Kalra PR, Foley RN, Kalra PA,. Left ventricular morphology and function in patients with atherosclerotic renovascular disease. J. Am. Soc. Nephrol. 2005; 16: 2746-53.
33. Wright JR, Shurrab AE, Cheung C, et al,. A prospective study of the determinants of renal functional outcome and mortality in atherosclerotic renovascular disease. Am. J. Kidney Dis. 2002; 39: 1153-61. (Pubitemid 34591929)
34. Guo H, Kalra PA, Gilbertson DT, et al,. Atherosclerotic renovascular disease in older US patients starting dialysis, 1996 to 2001. Circulation 2007; 115: 50-8. (Pubitemid 46058611)
35. Thadhani R, Pascual M, Nickeleit V, Tolkoff-Rubin N, Colvin R,. Preliminary description of focal segmental glomerulosclerosis in patients with renovascular disease. Lancet 1996; 347 (8996): 231-3. (Pubitemid 26035249)
36. Halimi JM, Ribstein J, Du Cailar G, Mimran A,. Nephrotic-range proteinuria in patients with renovascular disease. Am. J. Med. 2000; 108: 120-6. (Pubitemid 30064422)
37. Wright JR, Shurrab AE, Cooper A, Kalra PR, Foley RN, Kalra PA,. Progression of cardiac dysfunction in patients with atherosclerotic renovascular disease. QJM 2009; 102 (10): 695-704.
38. Makanjuola AD, Suresh M, Laboi P, Kalra PA, Scoble JE,. Proteinuria in atherosclerotic renovascular disease. QJM 1999; 92 (9): 515-18. (Pubitemid 29430049)
39. Suresh M, Laboi P, Mamtora H, Kalra PA,. Relationship of renal dysfunction to proximal arterial disease severity in atherosclerotic renovascular disease. Nephrol. Dial. Transplant. 2000; 15: 631-6. (Pubitemid 30242980)
40. Chrysochou C, Cheung CM, Durow M, et al,. Proteinuria as a predictor of renal functional outcome after revascularization in atherosclerotic renovascular disease (ARVD). QJM 2009; 102: 283-8.
41. Goldblatt H, Lynch J, Hanzal RF, Summerville WW,. Studies on experimental hypertension: I. The production of persistent elevation of systolic blood pressure by means of renal ischemia. J. Exp. Med. 1934; 59: 347-79.
42. Rimoldi SF, Yuzefpolskaya M, Allemann Y, Messerli F,. Flash pulmonary edema. Prog. Cardiovasc. Dis. 2009; 52: 249-59.
43. Marchais SJ, Guerin AP, Pannier BM, Levy BI, Safar ME, London GM,. Wave reflections and cardiac hypertrophy in chronic uremia. Influence of body size. Hypertension 1993; 22: 876-83. (Pubitemid 23358096)
44. de Simone G,. Left ventricular geometry and hypotension in end-stage renal disease: A mechanical perspective. J. Am. Soc. Nephrol. 2003; 14 (10): 2421-7. (Pubitemid 37169327)
45. Straumann E, Bertel O, Meyer B,. Symmetric and asymmetric left ventricular hypertrophy in patients with end-stage renal failure on long-term hemodialysis. Clin. Cardiol. 1998; 21 (9): 672-8. (Pubitemid 28420413)
46. Messina LM, Zelenock GB, Yao KA, Stanley JC,. Renal revascularization for recurrent pulmonary edema in patients with poorly controlled hypertension and renal insufficiency: A distinct subgroup of patients with arteriosclerotic renal artery occlusive disease. J. Vasc. Surg. 1992; 15: 73-80, discussion 80-2.
47. Wykrzykowska JJ, Williams M, Laham RJ,. Stabilization of renal function, improvement in blood pressure control and pulmonary edema symptoms after opening a totally occluded renal artery. J. Invas. Cardiol. 2008; 20: E26-9.
48. de Silva R, Nikitin NP, Bhandari S, Nicholson A, Clark AL, Cleland JG,. Atherosclerotic renovascular disease in chronic heart failure: Should we intervene? Eur. Heart J. 2005; 26 (16): 1596-605. (Pubitemid 41389689)
49. Mahony JF, Gibson GR, Sheil AG, Storey BG, Stokes GS, Stewart JH,. Bilateral nephrectomy for malignant hypertension. Lancet 1972; 1 (7759): 1036-8.
50. Jackson B, Matthews PG, McGrath BP, Johnston CI,. Angiotensin converting enzyme inhibition in renovascular hypertension: Frequency of reversible renal failure. Lancet 1984; 1 (8370): 225-6. (Pubitemid 14222014)
51. Constantina Chrysochou CC, Eddington H, Sinha S, Kalra P,. Dispelling the myth: Use of ACE-I/ARB in renovascular disease. ASN Renal Week 2007. 2007: San Francisco.
52. Chrysochou C, Sinha S, Chalmers N, Kalra PR, Kalra PA,. Anuric acute renal failure and pulmonary oedema: A case for urgent action. Int. J. Cardiol. 2009; 132: e31-3.
53. Granillo GA, van Dijk LC, McFadden EP, Serruys PW,. Percutaneous radial intervention for complex bilateral renal artery stenosis using paclitaxel eluting stents. Catheter Cardiovasc. Interv. 2005; 64: 23-7. (Pubitemid 40069887)
54. Nordmann AJ, Woo K, Parkes R, Logan AG,. Balloon angioplasty or medical therapy for hypertensive patients with atherosclerotic renal artery stenosis? A meta-analysis of randomized controlled trials. Am. J. Med. 2003; 114: 44-50. (Pubitemid 36126515)
55. Gill KS, Fowler RC,. Atherosclerotic renal arterial stenosis: Clinical outcomes of stent placement for hypertension and renal failure. Radiology 2003; 226: 821-6. (Pubitemid 36259160)
56. Dwyer KM, Vrazas JI, Lodge RS, et al,. Treatment of acute renal failure caused by renal artery occlusion with renal artery angioplasty. Am. J. Kidney Dis. 2002; 40: 189-94. (Pubitemid 34701228)
57. Shah S, Paparello J, Danesh FR,. Effects of statin therapy on the progression of chronic kidney disease. Adv. Chronic. Kidney Dis. 2005; 12: 187-95. (Pubitemid 40489001)
58. Cheung CM, Patel A, Shaheen N, et al,. The effects of statins on the progression of atherosclerotic renovascular disease. Nephron. Clin. Pract. 2007; 107: c35-42. (Pubitemid 47557266)
59. Silva VS, Martin LC, Franco RJ, et al,. Pleiotropic effects of statins may improve outcomes in atherosclerotic renovascular disease. Am. J. Hypertens. 2008; 21 (10): 1163-8.
60. Chade AR, Zhu XY, Grande JP, Krier JD, Lerman A, Lerman LO,. Simvastatin abates development of renal fibrosis in experimental renovascular disease. J. Hypertens. 2008; 26: 1651-60.
61. Zhu XY, Daghini E, Chade AR, et al,. Simvastatin prevents coronary microvascular remodeling in renovascular hypertensive pigs. J. Am. Soc. Nephrol. 2007; 18: 1209-17. (Pubitemid 46536907)
62. Chrysochou C, Kalra PA,. Current management of atherosclerotic renovascular disease-What have we learned from ASTRAL? Nephron. Clin. Pract. 2010; 115: c73-81.
63. Subramanian R, White CJ, Rosenfield K, et al,. Renal fractional flow reserve: A hemodynamic evaluation of moderate renal artery stenoses. Catheter Cardiovasc. Interv. 2005; 64: 480-6. (Pubitemid 40463446)
64. Attenberger UI, Sourbron SP, Schoenberg SO, et al,. Comprehensive MR evaluation of renal disease: Added clinical value of quantified renal perfusion values over single MR angiography. J. Magn. Reson. Imaging 2010; 31: 125-33.
65. Buckley DL, Shurrab AE, Cheung CM, Jones AP, Mamtora H, Kalra PA,. Measurement of single kidney function using dynamic contrast-enhanced MRI: Comparison of two models in human subjects. J. Magn. Reson. Imaging 2006; 24: 1117-23. (Pubitemid 44658250)
66. Schoenberg SO, Knopp MV, Londy F, et al,. Morphologic and functional magnetic resonance imaging of renal artery stenosis: A multireader tricenter study. J. Am. Soc. Nephrol. 2002; 13: 158-69. (Pubitemid 34042023)
67. Michaely HJ, Sourbron S, Dietrich O, Attenberger U, Reiser MF, Schoenberg SO,. Functional renal MR imaging: An overview. Abdom. Imaging 2006; 32: 758-71. (Pubitemid 350060488)
68. Cheung CM, Shurrab AE, Buckley DL, et al,. MR-derived renal morphology and renal function in patients with atherosclerotic renovascular disease. Kidney Int. 2006; 69: 715-22. (Pubitemid 43237641)
69. Cheung CM, Chrysochou C, Shurrab AE, Buckley DL, Cowie A, Kalra PA,. Effects of renal volume and single-kidney glomerular filtration rate on renal functional outcome in atherosclerotic renal artery stenosis. Nephrol. Dial. Transplant. 2010; 25: 1133-40.
70. Tuttle KR,. Renal parenchymal injury as a determinant of clinical consequences in atherosclerotic renal artery stenosis. Am. J. Kidney Dis. 2002; 39: 1321-2. (Pubitemid 34594128)
71. Roditi G, Maki JH, Oliveira G, Michaely HJ,. Renovascular imaging in the NSF Era. J. Magn. Reson. Imaging 2009; 30: 1323-34.
72. Maloney JP, Silliman CC, Ambruso DR, Wang J, Tuder RM, Voelkel NF,. In vitro release of vascular endothelial growth factor during platelet aggregation. Am. J. Physiol. 1998; 275 (3 Pt 2): H1054-61.
73. Schrijvers BF, Flyvbjerg A, De Vriese AS,. The role of vascular endothelial growth factor (VEGF) in renal pathophysiology. Kidney Int. 2004; 65: 2003-17. (Pubitemid 38669987)
74. Iliescu R, Fernandez SR, Kelsen S, Maric C, Chade AR,. Role of renal microcirculation in experimental renovascular disease. Nephrol. Dial. Transplant. 2010; 25: 1079-87.
75. Lai KN, Leung JC, Yandle TG, Fisher S, Nicholls MG,. Gene expression and synthesis of natriuretic peptides by cultured human glomerular cells. J. Hypertens. 1999; 17: 575-83. (Pubitemid 29308569)
76. Wiese S, Breyer T, Dragu A, et al,. Gene expression of brain natriuretic peptide in isolated atrial and ventricular human myocardium: Influence of angiotensin II and diastolic fiber length. Circulation 2000; 102 (25): 3074-9.
77. Wolf K, Kurtz A, Pfeifer M, Hocherl K, Riegger GA, Kramer BK,. Different regulation of left ventricular ANP, BNP and adrenomedullin mRNA in the two-kidney, one-clip model of renovascular hypertension. Pflugers Arch. 2001; 442: 212-17. (Pubitemid 32476639)
78. Silva JA, Chan AW, White CJ, et al,. Elevated brain natriuretic peptide predicts blood pressure response after stent revascularization in patients with renal artery stenosis. Circulation 2005; 111: 328-33. (Pubitemid 40165340)
79. Corriere MA, Edwards MS, Pearce JD, Andrews JS, Geary RL, Hansen KJ,. Restenosis after renal artery angioplasty and stenting: Incidence and risk factors. J. Vasc. Surg. 2009; 50: 813-19, e1.
80. Sapoval M, Zahringer M, Pattynama P, et al,. Low-profile stent system for treatment of atherosclerotic renal artery stenosis: The GREAT trial. J. Vasc. Interv. Radiol. 2005; 16 (9): 1195-202. (Pubitemid 41319756)
81. Zahringer M, Sapoval M, Pattynama PM, et al,. Sirolimus-eluting versus bare-metal low-profile stent for renal artery treatment (GREAT Trial): Angiographic follow-up after 6 months and clinical outcome up to 2 years. J. Endovasc. Ther. 2007; 14: 460-8. (Pubitemid 350154991)
82. Friedel JM, Khalil R, Lasorda D,. Treatment of iatrogenic renal artery perforation with a covered stent and subsequent rheolytic thrombectomy. J. Invas. Cardiol. 2005; 17 (7): 374-5.
83. Blackman DJ, Choudhury RP, Banning AP, Channon KM,. Failure of the Symbiot PTFE-covered stent to reduce distal embolization during percutaneous coronary intervention in saphenous vein grafts. J. Invas. Cardiol. 2005; 17 (11): 609-12.
84. Marin ML, Veith FJ, Cynamon J, et al,. Transfemoral endovascular stented graft treatment of aorto-iliac and femoropopliteal occlusive disease for limb salvage. Am. J. Surg. 1994; 168: 156-62. (Pubitemid 24332551)
85. Gaxotte V, Laurens B, Haulon S, Lions C, Mounier-Vehier C, Beregi JP,. Multicenter trial of the Jostent balloon-expandable stent-graft in renal and iliac artery lesions. J. Endovasc. Ther. 2003; 10: 361-5. (Pubitemid 36988614)
86. Waksman R, Robinson KA, Crocker IR, Gravanis MB, Cipolla GD, King SB, 3rd. Endovascular low-dose irradiation inhibits neointima formation after coronary artery balloon injury in swine. A possible role for radiation therapy in restenosis prevention. Circulation 1995; 91: 1533-9.
87. Lekston A, Chudek J, Wilczek K, et al,. Comparison of early and late efficacy of percutaneous transluminal renal angioplasty with or without subsequent brachytherapy: The effect on blood pressure in patients with renovascular hypertension. Cardiol. J. 2009; 16 (6): 514-20.
88. Lekston A, Niklewski T, Gasior M, et al,. Effects of short- and long-term efficacy of percutaneous transluminal renal angioplasty with or without intravascular brachytherapy on regression of left ventricular hypertrophy in patients with renovascular hypertension. Pol. Arch. Med. Wewn. 2009; 119 (4): 211-18.
89. Hiramoto J, Hansen KJ, Pan XM, Edwards MS, Sawhney R, Rapp JH,. Atheroemboli during renal artery angioplasty: An ex vivo study. J. Vasc. Surg. 2005; 41: 1026-30. (Pubitemid 40813034)
90. Kanjwal K, Haller S, Steffes M, et al,. Complete versus partial distal embolic protection during renal artery stenting. Catheter Cardiovasc. Interv. 2009; 73: 725-30.
91. Holden A, Hill A, Jaff MR, Pilmore H,. Renal artery stent revascularization with embolic protection in patients with ischemic nephropathy. Kidney Int. 2006; 70: 948-55. (Pubitemid 44285973)
92. Cooper CJ, Haller ST, Colyer W, et al,. Embolic protection and platelet inhibition during renal artery stenting. Circulation 2008; 117 (21): 2752-60. (Pubitemid 351771335)
93. Henry M, Henry I, Polydorou A, Hugel M,. Embolic protection for renal artery stenting. J. Cardiovasc. Surg. 2008; 49: 571-89.
94. Cooper CJ, Murphy TP, Matsumoto A, et al,. Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: Rationale and design of the CORAL trial. Am. Heart J. 2006; 152: 59-66. (Pubitemid 43974724)